Viewing Study NCT05575167


Ignite Creation Date: 2025-12-25 @ 12:40 AM
Ignite Modification Date: 2025-12-28 @ 2:50 AM
Study NCT ID: NCT05575167
Status: RECRUITING
Last Update Posted: 2025-04-27
First Post: 2022-10-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Single or Repeat Zoledronate Versus Alendronate Following Denosumab (EUROpean Denosumab Effects Consolidation Study)
Sponsor: 424 General Military Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module